Haemonetics Corp. sell Bank of America Co.
Start price
07.02.25
/
50%
€57.00
Target price
07.02.26
€65.59
Performance (%)
-15.09%
End price
08.02.26
€48.40
Summary
This prediction ended on 08.02.26 with a price of €48.40. The prediction for Haemonetics Corp. closed with a convincing performance of -15.09%. Bank_of_America_Co_ has a follow-up prediction for Haemonetics Corp., but this time predicts that Haemonetics Corp. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | 16.981% | 16.981% | - |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $68.00 price target on the stock, down previously from $95.00.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€55.50
22.05.26
22.05.26
€68.84
22.05.27
22.05.27
67.57%
20.08.26
20.08.26
